Dimensional Fund Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-303,785
| Closed | -$16M | – | 3382 |
|
|
2020
Q3 | $16M | Sell |
303,785
-6,081
| -2% | -$375K | 0.01% | 1961 |
|
|
2020
Q2 | $19M | Sell |
309,866
-558
| -0.2% | -$32.3K | 0.01% | 1903 |
|
|
2020
Q1 | $17.6M | Sell |
310,424
-5,024
| -2% | -$286K | 0.01% | 1838 |
|
|
2019
Q4 | $18M | Buy |
315,448
+5,086
| +2% | +$270K | 0.01% | 2099 |
|
|
2019
Q3 | $16.6M | Sell |
310,362
-726
| -0.2% | -$42.3K | 0.01% | 2111 |
|
|
2019
Q2 | $18.6M | Buy |
311,088
+7,428
| +2% | +$467K | 0.01% | 2087 |
|
|
2019
Q1 | $18.9M | Buy |
303,660
+14,417
| +5% | +$954K | 0.01% | 2087 |
|
|
2018
Q4 | $17.5M | Buy |
289,243
+8,132
| +3% | +$486K | 0.01% | 2053 |
|
|
2018
Q3 | $16.4M | Buy |
281,111
+9,849
| +4% | +$502K | 0.01% | 2223 |
|
|
2018
Q2 | $12.2M | Buy |
271,262
+1,612
| +0.6% | +$69.3K | ﹤0.01% | 2336 |
|
|
2018
Q1 | $12M | Sell |
269,650
-1,843
| -0.7% | -$77.4K | 0.01% | 2304 |
|
|
2017
Q4 | $11.8M | Buy |
271,493
+1,939
| +0.7% | +$87.2K | ﹤0.01% | 2315 |
|
|
2017
Q3 | $12.5M | Buy |
269,554
+3,878
| +1% | +$186K | 0.01% | 2265 |
|
|
2017
Q2 | $13.2M | Buy |
265,676
+18,562
| +8% | +$972K | 0.01% | 2232 |
|
|
2017
Q1 | $13.5M | Buy |
247,114
+17,774
| +8% | +$941K | 0.01% | 2186 |
|
|
2016
Q4 | $12.8M | Buy |
229,340
+30,210
| +15% | +$1.45M | 0.01% | 2201 |
|
|
2016
Q3 | $9.09M | Buy |
199,130
+20,879
| +12% | +$839K | ﹤0.01% | 2292 |
|
|
2016
Q2 | $7.12M | Buy |
178,251
+1,722
| +1% | +$63.1K | ﹤0.01% | 2362 |
|
|
2016
Q1 | $6.15M | Buy |
176,529
+7,655
| +5% | +$281K | ﹤0.01% | 2417 |
|
|
2015
Q4 | $7.26M | Buy |
168,874
+11,456
| +7% | +$574K | ﹤0.01% | 2359 |
|
|
2015
Q3 | $6.85M | Buy |
157,418
+26,396
| +20% | +$1.42M | ﹤0.01% | 2386 |
|
|
2015
Q2 | $6.76M | Buy |
131,022
+13,792
| +12% | +$588K | ﹤0.01% | 2446 |
|
|
2015
Q1 | $4.59M | Buy |
117,230
+18,475
| +19% | +$724K | ﹤0.01% | 2584 |
|
|
2014
Q4 | $3.81M | Buy |
98,755
+26,661
| +37% | +$1.02M | ﹤0.01% | 2659 |
|
|
2014
Q3 | $2.54M | Buy |
72,094
+6,260
| +10% | +$184K | ﹤0.01% | 2778 |
|
|
2014
Q2 | $1.77M | Buy |
65,834
+10,313
| +19% | +$269K | ﹤0.01% | 2892 |
|
|
2014
Q1 | $1.44M | Buy |
55,521
+6,509
| +13% | +$156K | ﹤0.01% | 2941 |
|
|
2013
Q4 | $1.06M | Buy |
49,012
+6,695
| +16% | +$137K | ﹤0.01% | 3023 |
|
|
2013
Q3 | $824K | Sell |
42,317
-2,100
| -5% | -$37.2K | ﹤0.01% | 3077 |
|
|
2013
Q2 | $693K | Buy |
+44,417
| New | +$715K | ﹤0.01% | 3096 |
|
Other funds holding BSTC
Dimensional Fund Advisors's BSTC Position: Q4 2020 in Review
Dimensional Fund Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 303,785 shares — an estimated $16M sold.
Dimensional Fund Advisors first reported a position in BSTC in Q2 2013 and held it in 30 quarters. The position peaked at $19M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Dimensional Fund Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Dimensional Fund Advisors sold 303,785 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $16M.
- Dimensional Fund Advisors first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 30 quarters.
- Dimensional Fund Advisors's BioSpecifics Technologies Corp. position peaked at $19M in Q2 2020.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Dimensional Fund Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.